Related Experiment Video
Updated: Jan 20, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
In Search for Methods to Support Electronic Patient Recruitment in a Multi-ICU Clinical Trial
Katharina Diesch1, Jürgen Held2, Stefan Kraus3
1Center for Medical Information and Communication Technology, Universitätsklinikum Erlangen, Erlangen, Germany.
Abstract:
Antimycotics are substances to treat fungal infections, a frequent cause of death on intensive care units. It is of great importance to administer such drugs only to patients who actually need them, since the unnecessary application leads to the selection of multiresistent fungi, making future therapy more difficult, and represents a significant financial burden for the health care system. Within the scope of a prospective study, which analyses the premature discontinuation of the administration of unnecessary antifungal drugs, two software platforms for recruitment support were implemented and compared at the University Hospital Erlangen. Besides technical aspects, such as the necessary development time and query runtimes, their usability and user friendliness for the clinical users were compared. We found that the practical identification of patient cohorts is possible both with a full featured business intelligence application and with a low effort approach based on language constructs of the Arden Syntax. Furthermore, this pilot evaluation led to important insights related to the clinical documentation context and data quality issues. A comprehensive analysis of the clinical environment and documentation context is essential for the final decision on the tool to be used.
Insights
Identifying patients for antifungal drug discontinuation is feasible using business intelligence or Arden Syntax software. This helps prevent multidrug-resistant fungi and reduces healthcare costs.
Area of Science:
- Medical Informatics
- Clinical Pharmacology
Background:
- Antifungal drugs treat fungal infections, a common cause of death in intensive care units.
- Unnecessary use of antifungals drives multidrug resistance and increases healthcare expenses.
Purpose of the Study:
- To compare two software platforms for identifying patients eligible for premature discontinuation of unnecessary antifungal drugs.
- To evaluate technical aspects and user-friendliness of recruitment support software.
Main Methods:
- A prospective study was conducted at University Hospital Erlangen.
- Two software platforms, a business intelligence application and an Arden Syntax-based approach, were implemented and compared.
- Technical aspects (development time, query runtimes) and usability were assessed.
Main Results:
- Both software platforms effectively identified patient cohorts for premature discontinuation of antifungal therapy.
- The Arden Syntax approach offered a low-effort alternative to a full business intelligence application.
- Insights into clinical documentation context and data quality were gained.
Conclusions:
- Practical identification of patient cohorts for antifungal stewardship is achievable with different software solutions.
- The choice of software depends on a thorough analysis of the clinical environment and documentation context.
- Optimizing antifungal drug use is crucial for combating resistance and managing healthcare costs.
Related Concept Videos
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Clinical Trials
There are four phases in a clinical trial. A phase one...
09:09In Silico Clinical Trials for Cardiovascular Disease
Clinical Trials: Overview
06:32Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation
06:04Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex

